BeiGene Ltd ADR buy melinda
Start price
02.04.19
/
50%
€124.64
Target price
04.11.21
€250.00
Performance (%)
158.35%
End price
05.11.21
€322.00
Summary
This prediction ended on 05.11.21 with a price of €322.00. The BUY prediction by melinda for BeiGene Ltd ADR saw massive gains of 158.35%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
BeiGene Ltd ADR | 7.857% | 7.857% | -17.486% | -35.470% |
iShares Core DAX® | 1.280% | 1.320% | 13.605% | 15.782% |
iShares Nasdaq 100 | -2.457% | -5.192% | 25.941% | 38.434% |
iShares Nikkei 225® | -2.006% | -1.389% | 8.973% | 6.570% |
iShares S&P 500 | -0.662% | -1.884% | 23.684% | 39.611% |
Comments by melinda for this prediction
In the thread Beigene Ltd ADR diskutieren
a suivre
Zanubrutinib (BGB-3111)
Phase 2
Relapsed or refractory mantle cell lymphoma (MCL)
1H 201906/30/2019
Phase 2 updated data due 1H 2019.
Kursziel geändert auf 250,0
In the thread Trading Beigene Ltd ADR
Die von melinda gewählte maximale Laufzeit wurde überschritten
Stopped prediction by melinda for BeiGene Ltd ADR
BeiGene Ltd ADR
Start price
Target price
Perf. (%)
€109.65
12.11.18
12.11.18
€144.32
28.11.18
28.11.18
19.77%
28.11.18
28.11.18